Abstract: The present invention relates to a pyrimidodiazepine derivative or a pharmaceutically acceptable salt thereof and a use thereof. A pyrimidodiazepine derivative or a pharmaceutically acceptable salt thereof according to the present invention can bind specifically to DNAJC3 and PDIA3, which are inhibitory of PERK signaling activation, to prevent the inhibition against PERK signaling. Thus, having an advantage of effectively suppressing or inhibiting tau aggregation, the pyrimidodiazepine derivative or a pharmaceutically acceptable salt thereof can not only be used in a pharmaceutical composition capable of fundamentally preventing or treating tauopathies associated with the activation of tau protein, but also can find applications in various studies on the development of therapeutic agents for tauopathies, and the expression or activity inhibition of tau protein.

Abstract: The present invention relates to a novel phosphor-tetrazine and a use thereof and, more particularly, provides a novel compound having high fluorescence amplification efficiency in various wavelength ranges by using a compound having a novel core skeleton called tert-butyl (3-(7-(6-methyl-1,2,4,5-tetrazin-3-yl)-3-oxo-9-phenyl-1H-pyrrolo[3,4-b]indolizin-2(3H)-yl)propyl)carbamate.

Abstract: The present invention is related to a novel pyrimidine derivative compound or a pharmaceutically acceptable salt thereof, a process for preparing the same, and a pharmaceutical composition using the same.

Abstract: Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

Abstract: Disclosed herein are an impact-absorbing apparatus and method for a vehicle, which are applied to an automatic emergency brake (AEB) system of a vehicle. The impact-absorbing apparatus includes a path generation unit configured to generate an own vehicle travel path of an own vehicle, based on a speed and travel direction of the own vehicle, and a preceding vehicle travel path of a preceding vehicle, based on a speed and travel direction of the preceding vehicle, and a collision determination unit configured to determine whether or not the own vehicle collides with the preceding vehicle, based on the own vehicle travel path and the preceding vehicle travel path, wherein when it is impossible to avoid the collision between the own vehicle and the preceding vehicle, the path generation unit generates a new travel path by comparing the own vehicle travel path with the preceding vehicle travel path.

Abstract: The present invention relates to a method for identifying a target protein using a thermal stability shift-based fluorescence difference in two-dimensional gel electrophoresis, and more specifically, a method for identifying a protein, which is a target of a specific drug, by analyzing, by means of a fluorescence difference in two-dimensional gel electrophoresis, a thermal stability shift in the protein when a specific drug, preferably a bioactive molecule, binds to the target protein.

Abstract: The present invention relates to a novel phosphor-tetrazine and a use thereof and, more particularly, provides a novel compound having high fluorescence amplification efficiency in various wavelength ranges by using a compound having a novel core skeleton called tert-butyl (3-(7-(6-methyl-1,2,4,5-tetrazin-3 -yl)-3-oxo-9-phenyl-1H-pyrrolo[3,4-b]indolizin-2(3H)-yl)propyl)carbamate.

Abstract: Disclosed are a miserite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass. A miserite crystallized glass for an artificial tooth according to the present invention is colored with any one of the shades in groups A, B, C and D of the Vita shade guide which is a tooth shade reference. The miserite crystallized glass has a miserite crystal phase as the main phase and comprises a hydroxyapatite crystal phase and a xonotlite crystal phase as additional phases.

Abstract: Disclosed are a wollastonite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass.

Abstract: The present invention provides a fluorescent resveratrone [(E)-4-(6,8-dihydroxynaphthalen-2-yl)but-3-en-2-one] and its derivatives having Formula 1 and a method for preparing the same by a photochemical reaction of resveratrol and its derivatives which are not fluorescent having Formula 7 or Formula 8. The new fluorescent compounds of the present invention has single-photon absorptive characteristics and/or two-photon absorptive characteristics as well as no or little toxicity according to a cytotoxicity test and can be usefully utilized in the field of organic fluorescent element, display element, spectrometer, two-photon absorptive storing device, laser micro processing apparatus, photo dynamic therapy apparatus and the like.

Abstract: The present invention is related to a novel pyrimidine derivative compound or a pharmaceutically acceptable salt thereof, a process for preparing the same, and a pharmaceutical composition using the same.

Abstract: The present invention provides a fluorescent resveratrone [(E)-4-(6,8-dihydroxynaphthalen-2-yl)but-3-en-2-one] and its derivatives having Formula 1 and a method for preparing the same by a photochemical reaction of resveratrol and its derivatives which are not fluorescent having Formula 7 or Formula 8. The new fluorescent compounds of the present invention has single-photon absorptive characteristics and/or two-photon absorptive characteristics as well as no or little toxicity according to a cytotoxicity test and can be usefully utilized in the field of organic fluorescent element, display element, spectrometer, two-photon absorptive storing device, laser micro processing apparatus, photo dynamic therapy apparatus and the like.

Abstract: Disclosed are a miserite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass. A miserite crystallized glass for an artificial tooth according to the present invention is colored with any one of the shades in groups A, B, C and D of the Vita shade guide which is a tooth shade reference. The miserite crystallized glass has a miserite crystal phase as the main phase and comprises a hydroxyapatite crystal phase and a xonotlite crystal phase as additional phases.

Abstract: Disclosed are a wollastonite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass.

Abstract: The present invention relates to a method for identifying a target protein using a thermal stability shift-based fluorescence difference in two-dimensional gel electrophoresis, and more specifically, a method for identifying a protein, which is a target of a specific drug, by analyzing, by means of a fluorescence difference in two-dimensional gel electrophoresis, a thermal stability shift in the protein when a specific drug, preferably a bioactive molecule, binds to the target protein.

Abstract: Disclosed is a method of manufacturing a multilayer zirconia block for artificial teeth, including a first material mixing step of mixing a 3 mol % yttrium oxide-tetragonal zirconia polycrystal and an organic binder, a second material mixing step of mixing a 3 mol % yttrium oxide-tetragonal zirconia polycrystal, a 5 mol % yttrium oxide-tetragonal zirconia polycrystal and an organic binder, a third material mixing step of mixing a 5 mol % yttrium oxide-tetragonal zirconia polycrystal and an organic binder, a compression molding step of sequentially placing the mixtures obtained in the first material mixing step, the second material mixing step, and the third material mixing step in a mold for compression molding and performing compression molding, and a calcination step of calcining a compression molded product obtained in the compression molding step.

Abstract: The present invention relates a novel compound represented by the following Formula 3 or Formula 5, and a pharmaceutical composition having superior anti-inflammatory effect comprising the above. The above compound inhibits the translocation of HMGB1 form nucleus to cytosol, and then has remarkable effect of treating or preventing inflammatory disease, especially sepsis.

Abstract: Disclosed herein are an impact-absorbing apparatus and method for a vehicle, which are applied to an automatic emergency brake (AEB) system of a vehicle. The impact-absorbing apparatus includes a path generation unit configured to generate an own vehicle travel path of an own vehicle, based on a speed and travel direction of the own vehicle, and a preceding vehicle travel path of a preceding vehicle, based on a speed and travel direction of the preceding vehicle, and a collision determination unit configured to determine whether or not the own vehicle collides with the preceding vehicle, based on the own vehicle travel path and the preceding vehicle travel path, wherein when it is impossible to avoid the collision between the own vehicle and the preceding vehicle, the path generation unit generates a new travel path by comparing the own vehicle travel path with the preceding vehicle travel path.

Abstract: Disclosed is a method of manufacturing a multilayer zirconia block for artificial teeth, including a first material mixing step of mixing a 3 mol % yttrium oxide-tetragonal zirconia polycrystal and an organic binder, a second material mixing step of mixing a 3 mol % yttrium oxide-tetragonal zirconia polycrystal, a 5 mol % yttrium oxide-tetragonal zirconia polycrystal and an organic binder, a third material mixing step of mixing a 5 mol % yttrium oxide-tetragonal zirconia polycrystal and an organic binder, a compression molding step of sequentially placing the mixtures obtained in the first material mixing step, the second material mixing step, and the third material mixing step in a mold for compression molding and performing compression molding, and a calcination step of calcining a compression molded product obtained in the compression molding step.

Abstract: Disclosed herein is an anti-inflammatory pharmaceutical composition comprising a benzopyranyl tetracycle compound represented by Chemical Formula 1 as an active ingredient. The compound exhibits excellent anti-inflammatory activity by perturbing the post-translational modification of the inflammation mediator HMGB, and thus finds applications in pharmaceutical compositions superior in the treatment or prevention of inflammation-related diseases.